THC effects in older adults trial
Part of Brain & nervous system clinical trials.
This trial studies how a single dose of THC (the active ingredient in cannabis) affects older adults. It aims to understand the effects in this age group, which may help guide safe use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can understand and agree to the study procedures.
- You do not have a serious or unstable medical, brain, or mental health condition, either now or in the past.
- You have a high school diploma or equivalent.
- If you can become pregnant, you are not pregnant, nursing, or planning to nurse during the study.
- You speak English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early study measures how a THC dose (by mouth or vaporized form) moves through the body and how it affects the body’s responses. It mainly looks at safety and how THC behaves in older adults, including people who have used cannabis before.
This study uses brain scans (fMRI) to see how THC (the active ingredient in cannabis) affects the brain as people age. If you are a cannabis user without current dependence or health issues, you may help researchers understand these effects.
This Phase 1 study tests how THC (the main active ingredient in cannabis) affects healthy adults, and whether effects differ by gender. It’s designed to learn about short-term body and brain responses to THC.
This Phase 1 study tests how delta-9 THC (the main active ingredient in cannabis) affects healthy adults, and whether the effects differ by gender. It may help researchers understand risks and responses to THC, which could guide safer use and future treatments.
This Phase 2 study looks at how THC (from cannabis) changes brain signals during working memory tasks. It uses EEG and MEG (noninvasive brain recording) to understand changes in “neural noise” and how well information moves through memory networks.
This Phase 1 study looks at how THC (the main mind-altering ingredient in cannabis) affects healthy volunteers shortly after use. It focuses on differences between people and includes those who have used cannabis before.
Hear when a new Age-related Cognitive Decline trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.